0

Gastroenterology/Hepatology Collection
 221-240 of 2621 Articles
Editorials |  15 October 2002
Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores
Leonard E. Braitman, PhD; Paul R. Rosenbaum, PhD
Ann Intern Med. 2002;137(8):693-695. doi:10.7326/0003-4819-137-8-200210150-00015
Articles |  1 October 2002
Prevalence of bcl-2 Rearrangement in Patients with Hepatitis C Virus–Related Mixed Cryoglobulinemia with or without B-Cell Lymphomas
Anna Linda Zignego, MD, PhD; Clodoveo Ferri, MD; Francesca Giannelli, PhD; et al.
Ann Intern Med. 2002;137(7):571-580. doi:10.7326/0003-4819-137-7-200210010-00008
Reviews |  1 October 2002
The Genetics of Colorectal Cancer
Paula M. Calvert, MD; Harold Frucht, MD
Ann Intern Med. 2002;137(7):603-612. doi:10.7326/0003-4819-137-7-200210010-00012
Articles |  16 July 2002 FREE
Cost-Effectiveness Analyses of Colorectal Cancer Screening: A Systematic Review for the U.S. Preventive Services Task Force
Michael Pignone, MD, MPH; Somnath Saha, MD, MPH; Tom Hoerger, PhD; et al.
Ann Intern Med. 2002;137(2):96-104. doi:10.7326/0003-4819-137-2-200207160-00007
Articles |  2 July 2002
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
Daniele Prati, MD; Emanuela Taioli, MD, PhD; Alberto Zanella, MD; et al.
Ann Intern Med. 2002;137(1):1-10. doi:10.7326/0003-4819-137-1-200207020-00006
Editorials |  2 July 2002
Alanine Aminotransferase Levels: What's Normal?
Marshall M. Kaplan, MD
Ann Intern Med. 2002;137(1):49-51. doi:10.7326/0003-4819-137-1-200207020-00012
Academia and the Profession |  18 June 2002
Truth Survival in Clinical Research: An Evidence-Based Requiem?
Thierry Poynard, MD, PhD; Mona Munteanu, MD; Vlad Ratziu, MD; et al.
Ann Intern Med. 2002;136(12):888-895. doi:10.7326/0003-4819-136-12-200206180-00010
Reviews |  21 May 2002
Approach to the Patient with Chronic Hepatitis C Virus Infection
Steven K. Herrine, MD
Ann Intern Med. 2002;136(10):747-757. doi:10.7326/0003-4819-136-10-200205210-00010
Articles |  7 May 2002
Public Expectations and Attitudes for Annual Physical Examinations and Testing
Sylvia K. Oboler, MD; Allan V. Prochazka, MD, MSc; Ralph Gonzales, MD, MPH; et al.
Ann Intern Med. 2002;136(9):652-659. doi:10.7326/0003-4819-136-9-200205070-00007
Brief Communications |  7 May 2002
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Pietro Muretto, MD; Emanuele Angelucci, MD; Guido Lucarelli, MD
Ann Intern Med. 2002;136(9):667-672. doi:10.7326/0003-4819-136-9-200205070-00009
Therapeutics |  May/Jun 2002
Review: Hemoccult screening reduces death from colorectal cancer in average-risk patients > 50 years of age
Robert Fletcher, MD, MSc
Ann Intern Med. 2002;136(3):91. doi:10.7326/ACPJC-2002-136-3-091
Therapeutics |  May/Jun 2002
Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
Gurinder Luthra, MD; P. Jay Pasricha, MD
Ann Intern Med. 2002;136(3):92. doi:10.7326/ACPJC-2002-136-3-092
Therapeutics |  May/Jun 2002
Enteral nutrition led to fewer postoperative complications than did parenteral feeding in gastrointestinal cancer
Ronald L. Koretz, MD
Ann Intern Med. 2002;136(3):93. doi:10.7326/ACPJC-2002-136-3-093
Therapeutics |  May/Jun 2002
Nadolol and isosorbide prevented recurrent variceal bleeding better than did endoscopic ligation in cirrhosis
Hubert H. Nietsch, MD; Kris V. Kowdley, MD
Ann Intern Med. 2002;136(3):94. doi:10.7326/ACPJC-2002-136-3-094
Therapeutics |  May/Jun 2002
Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis
W. A. Hoogerwerf, MD; P. Jay Pasricha, MD
Ann Intern Med. 2002;136(3):95. doi:10.7326/ACPJC-2002-136-3-095
Resource Corner |  May/Jun 2002
The Desktop Guide to Complementary and Alternative Medicine: An Evidence-based Approach
Kumanan Wilson, MD
Ann Intern Med. 2002;136(3):A14. doi:10.7326/ACPJC-2002-136-3-A14
Brief Communications |  16 April 2002
Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix
Joya T. Favreau, MD; Mina L. Ryu, MD; Glenn Braunstein, MD; et al.
Ann Intern Med. 2002;136(8):590-595. doi:10.7326/0003-4819-136-8-200204160-00008
Brief Communications |  19 March 2002
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
Louis D. May, MD; Jay H. Lefkowitch, MD; Michael T. Kram, MD; et al.
Ann Intern Med. 2002;136(6):449-452. doi:10.7326/0003-4819-136-6-200203190-00008
Ideas and Opinions |  19 March 2002
Deconstructing the Placebo Effect and Finding the Meaning Response
Daniel E. Moerman, PhD; Wayne B. Jonas, MD
Ann Intern Med. 2002;136(6):471-476. doi:10.7326/0003-4819-136-6-200203190-00011
Editorials |  19 March 2002
“Did This Drug Cause My Patient's Hepatitis?” and Related Questions
David W. Nierenberg, MD
Ann Intern Med. 2002;136(6):480-483. doi:10.7326/0003-4819-136-6-200203190-00013
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)